Gene · 5452
Papers3,227
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 3,227
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Spermatocytic Tumor: A Review. | Int J Mol Sci | 2023 | 37298487 | PubTator, text mining | PubMed |
| Interleukin-33: Friend or Foe in Gastrointestinal Tract Cancers? | Cells | 2023 | 37296602 | PubTator, text mining | PubMed |
| Mechanistic inhibition of Monkeypox and Marburg virus infection by O-rhamnosides and Kaempferol-o-rhamnosides derivatives: a new-fangled computational approach. | Front Cell Infect Microbiol | 2023 | 37293201 | PubTator, text mining | PubMed |
| Gray zone lymphoma: A case report and comprehensive review of literature. | Leuk Res Rep | 2023 | 37287497 | PubTator, text mining | PubMed |
| Efficacy of vitamin K on bone fragility: puzzling findings from which we should learn how to design a rigorous study. | Nephrol Dial Transplant | 2023 | 37279891 | PubTator, text mining | PubMed |
| In silico screening, ADMET analysis and MD simulations of phytochemicals of Onosma bracteata Wall. as SARS CoV-2 inhibitors. | 3 Biotech | 2023 | 37265541 | PubTator, text mining | PubMed |
| A Phase I Trial of the Dual MET Kinase/OCT-2 Inhibitor OMO-1 in Metastatic Solid Malignancies Including MET Exon 14 Mutated Lung Cancer. | Oncologist | 2023 | 37260332 | PubTator, text mining | PubMed |
| Biologically Potent Benzimidazole-Based-Substituted Benzaldehyde Derivatives as Potent Inhibitors for Alzheimer's Disease along with Molecular Docking Study. | Pharmaceuticals (Basel) | 2023 | 37259358 | PubTator, text mining | PubMed |
| Mediastinal gray zone lymphoma in a pregnant woman presenting with cardiac tamponade. | Cardiooncology | 2023 | 37259152 | PubTator, text mining | PubMed |
| Chikungunya virus infection induces ultrastructural changes and impaired neuronal differentiation of human neurospheres. | Front Microbiol | 2023 | 37250062 | PubTator, text mining | PubMed |
| Impact of Thyroid Cancer Treatment on Renal Function: A Relevant Issue to Be Addressed. | J Pers Med | 2023 | 37240983 | PubTator, text mining | PubMed |
| Role of Extracellular Vesicles in Liver Diseases. | Life (Basel) | 2023 | 37240762 | PubTator, text mining | PubMed |
| Effects of Deacetylase Inhibition on the Activation of the Antioxidant Response and Aerobic Metabolism in Cellular Models of Fanconi Anemia. | Antioxidants (Basel) | 2023 | 37237966 | PubTator, text mining | PubMed |
| Amelogenesis imperfecta: Next-generation sequencing sheds light on Witkop's classification. | Front Physiol | 2023 | 37228816 | PubTator, text mining | PubMed |
| Zavegepant: First Approval. | Drugs | 2023 | 37227596 | PubTator, text mining | PubMed |
| Integrating intracellular and extracellular proteomic profiling for in-depth investigations of cellular communication in a model of prostate cancer. | Proteomics | 2023 | 37226375 | PubTator, text mining | PubMed |
| Incubation Time Influences Organic Anion Transporter 1 Kinetics and Renal Clearance Predictions. | J Xenobiot | 2023 | 37218810 | PubTator, text mining | PubMed |
| MEF2B is the ideal immunohistochemical marker to highlight neoplastic LP cells in nodular lymphocyte-predominant Hodgkin lymphoma. | EJHaem | 2023 | 37206275 | PubTator, text mining | PubMed |
| The miR-148/152 family contributes to angiogenesis of human pluripotent stem cell- derived endothelial cells by inhibiting MEOX2. | Mol Ther Nucleic Acids | 2023 | 37200858 | PubTator, text mining | PubMed |
| High expression of transcription factor POU2F1 confers improved survival on smokers with lung adenocarcinoma: a retrospective study of two cohorts. | Transl Lung Cancer Res | 2023 | 37197633 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5452/papers?page=19